Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling

Abstract Background Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have emerged as a powerful tool for disease modeling, though their immature nature currently limits translation into clinical practice. Maturation strategies increasingly pay attention to cardiac metabolism because o...

Full description

Bibliographic Details
Published in:	Stem Cell Research & Therapy
Main Authors:	Sofija Vučković, Rafeeh Dinani, Edgar E. Nollet, Diederik W. D. Kuster, Jan Willem Buikema, Riekelt H. Houtkooper, Miranda Nabben, Jolanda van der Velden, Birgit Goversen
Format:	Article
Language:	English
Published:	BMC 2022-07-01
Subjects:	iPSC Stem cells Cardiomyocyte Metabolism Maturation HCM
Online Access:	https://doi.org/10.1186/s13287-022-03021-9

Similar Items

iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01)

Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
by: Qianliang Yuan, et al.
Published: (2022-01-01)

Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies
by: Albin A. Bernardin, et al.
Published: (2022-11-01)

iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
by: Chithra K. Pushpan, et al.
Published: (2024-08-01)

Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes?
by: David Sergeevichev, et al.
Published: (2022-01-01)

Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping
by: Ding-Jun Hao, et al.
Published: (2024-03-01)

Enhancing Mitochondrial Maturation in iPSC-DerivedCardiomyocytes: Strategies for Metabolic Optimization
by: Dhienda C. Shahannaz, et al.
Published: (2025-07-01)

Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs
by: Ignacio Reinal, et al.
Published: (2023-07-01)

A generally conserved response to hypoxia in iPSC-derived cardiomyocytes from humans and chimpanzees
by: Michelle C Ward, et al.
Published: (2019-04-01)

Single-cell RNA sequencing reveals key regulators and differentiation trajectory of iPSC-derived cardiomyocytes
by: Lu Li, et al.
Published: (2024-11-01)

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes
by: Tadahiro Shinozawa, et al.
Published: (2017-02-01)

Pericellular oxygen dynamics in human cardiac fibroblasts and iPSC-cardiomyocytes in high-throughput plates: insights from experiments and modeling
by: Weizhen Li, et al.
Published: (2025-09-01)

Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency
by: Josè Manuel Pioner, et al.
Published: (2022-11-01)

Corrigendum: Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: the impact of full-length dystrophin deficiency
by: Josè Manuel Pioner, et al.
Published: (2023-06-01)

Particulate matter from car exhaust alters function of human iPSC-derived microglia
by: Henna Jäntti, et al.
Published: (2024-02-01)

Age-Dependent Maturation of iPSC-CMs Leads to the Enhanced Compartmentation of β<sub>2</sub>AR-cAMP Signalling
by: Alveera Hasan, et al.
Published: (2020-10-01)

WIN 55,212-2 shows anti-inflammatory and survival properties in human iPSC-derived cardiomyocytes infected with SARS-CoV-2
by: Luiz Guilherme H. S. Aragão, et al.
Published: (2021-10-01)

Comparison of two protocols for the generation of iPSC-derived human astrocytes
by: Patrycja Mulica, et al.
Published: (2023-09-01)

The role and mechanism of NRG1/ErbB4 in inducing the differentiation of induced pluripotent stem cells into cardiomyocytes
by: Xiaoou Li, et al.
Published: (2024-10-01)

iPSC-derived lung and lung cancer organoid model to evaluate cisplatin encapsulated autologous iPSC-derived mesenchymal stromal cell-isolated extracellular vesicles
by: Caroline Küstermann, et al.
Published: (2024-08-01)

Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology
by: Maria R. Pozo, et al.
Published: (2022-01-01)

Mending an infarcted heart: The possibility of using iPSC technology
by: Fei Li
Published: (2016-12-01)

Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions
by: Jyotsna Joshi, et al.
Published: (2024-09-01)

Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening
by: Chia-Yu Chang, et al.
Published: (2020-04-01)

Optogenetic‐Controlled iPSC‐Based Vaccines for Prophylactic and Therapeutic Tumor Suppression in Mice
by: Longliang Qiao, et al.
Published: (2025-09-01)

Tau aggregation induces cell death in iPSC-derived neurons
by: Hirokazu Tanabe, et al.
Published: (2025-01-01)

Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models
by: Alexandra Bizy, et al.
Published: (2020-09-01)

Impaired Relaxation in Induced Pluripotent Stem Cell‐Derived Cardiomyocytes with Pathogenic TNNI3 Mutation of Pediatric Restrictive Cardiomyopathy
by: Renjie Wang, et al.
Published: (2024-03-01)

Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model [version 1; peer review: 1 approved, 2 approved with reservations]
by: Chris Denning, et al.
Published: (2023-09-01)

Generation of a human iPSC-derived cardiomyocyte/fibroblast engineered heart tissue model [version 2; peer review: 1 approved, 2 approved with reservations]
by: Chris Denning, et al.
Published: (2024-02-01)

Brain organoid models for studying the function of iPSC-derived microglia in neurodegeneration and brain tumours
by: Angelica Maria Sabogal-Guaqueta, et al.
Published: (2024-12-01)

Mitochondrial Phenotypes in Parkinson’s Diseases—A Focus on Human iPSC-Derived Dopaminergic Neurons
by: Leonie M. Heger, et al.
Published: (2021-12-01)

Fail-Safe System against Potential Tumorigenicity after Transplantation of iPSC Derivatives
by: Go Itakura, et al.
Published: (2017-03-01)

Inhibition of SARS-CoV-2 infection in human iPSC-derived cardiomyocytes by targeting the Sigma-1 receptor disrupts cytoarchitecture and beating
by: José Alexandre Salerno, et al.
Published: (2021-12-01)

Cell cycle visualization tools to study cardiomyocyte proliferation in real-time
by: Rustem Salmenov, et al.
Published: (2024-10-01)

The restoration of REST inhibits reactivity of Down syndrome iPSC-derived astrocytes
by: Tan Huang, et al.
Published: (2025-03-01)

Generation of corrected-hiPSC (USTCi001-A-1) from epilepsy patient iPSCs using TALEN-mediated editing of the SCN1A gene
by: Huifang Zhao, et al.
Published: (2020-07-01)

iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death
by: Daria Messelodi, et al.
Published: (2021-10-01)

Matured hiPSC-derived cardiomyocytes possess dematuration plasticity
by: Fang Meng, et al.
Published: (2025-06-01)

Rock inhibitor may compromise human induced pluripotent stem cells for cardiac differentiation in 3D
by: Bin Jiang, et al.
Published: (2022-03-01)